The city’s pharma giants avoided much of the initial turbulence felt by the rest of the economy in the wake of President ...

Lockheed Martin Corp. (NYSE: LMT) announced it has delivered the first U.S. Air Force TPY-4 radar after successfully ...

NY-ESO-1, MAGE-A3, tyrosinase, and TPTE. The recruitment of BioNTech as a partner in melanoma comes after Regeneron and Sanofi decided to abandon development of Libtayo with their recently ...

PE-backed specialty pharma company Kelso Pharma appointed Giovanni Mauri as general manager of its recently acquired Italian ...

All three major averages (DJI, GSPC, IXIC) opened Wednesday's trading session in the red, weighed down by escalating trade ...

Three YPIE RegeneronScience Research Scholars, Loremy, Adrianna, and Maya were accepted to State Senate Majority ...

Learn about the achievements of ISEF finalists and Genius Olympiad finalists at the regional science fair, including high ...

Regeneron Pharmaceuticals Inc. closed 54.89% short of its 52-week high of $1,211.20, which the company reached on August 27th ...

Guggenheim analyst Yatin Suneja lowered the firm’s price target on Regeneron (REGN) to $940 from $950 and keeps a Buy rating on the shares. The ...

Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...